PMV Pharmaceuticals Inc (PMVP)
2.085
+0.10
(+4.77%)
USD |
NASDAQ |
May 06, 16:00
2.085
0.00 (0.00%)
After-Hours: 20:00
PMV Pharmaceuticals Price to Book Value: 0.4753 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 0.4536 |
| May 02, 2024 | 0.4262 |
| May 01, 2024 | 0.424 |
| April 30, 2024 | 0.4103 |
| April 29, 2024 | 0.4035 |
| April 26, 2024 | 0.3989 |
| April 25, 2024 | 0.3898 |
| April 24, 2024 | 0.3852 |
| April 23, 2024 | 0.4114 |
| April 22, 2024 | 0.3943 |
| April 19, 2024 | 0.367 |
| April 18, 2024 | 0.3693 |
| April 17, 2024 | 0.367 |
| April 16, 2024 | 0.3647 |
| April 15, 2024 | 0.3727 |
| April 12, 2024 | 0.408 |
| April 11, 2024 | 0.3601 |
| April 10, 2024 | 0.3442 |
| April 09, 2024 | 0.3601 |
| April 08, 2024 | 0.3556 |
| April 05, 2024 | 0.3647 |
| April 04, 2024 | 0.3647 |
| April 03, 2024 | 0.3875 |
| April 02, 2024 | 0.408 |
| April 01, 2024 | 0.4057 |
| Date | Value |
|---|---|
| March 28, 2024 | 0.3875 |
| March 27, 2024 | 0.3761 |
| March 26, 2024 | 0.3784 |
| March 25, 2024 | 0.3875 |
| March 22, 2024 | 0.3852 |
| March 21, 2024 | 0.3921 |
| March 20, 2024 | 0.3807 |
| March 19, 2024 | 0.3852 |
| March 18, 2024 | 0.3807 |
| March 15, 2024 | 0.4012 |
| March 14, 2024 | 0.3761 |
| March 13, 2024 | 0.3647 |
| March 12, 2024 | 0.3761 |
| March 11, 2024 | 0.3715 |
| March 08, 2024 | 0.3875 |
| March 07, 2024 | 0.424 |
| March 06, 2024 | 0.4399 |
| March 05, 2024 | 0.4285 |
| March 04, 2024 | 0.4262 |
| March 01, 2024 | 0.4274 |
| February 29, 2024 | 0.4217 |
| February 28, 2024 | 0.4126 |
| February 27, 2024 | 0.4285 |
| February 26, 2024 | 0.4103 |
| February 23, 2024 | 0.3807 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2648
Minimum
Oct 25 2023
11.05
Maximum
Sep 29 2020
2.519
Average
2.221
Median
Price to Book Value Benchmarks
| Exelixis Inc | 2.998 |
| Geron Corp | 6.407 |
| Verastem Inc | 5.245 |
| Karyopharm Therapeutics Inc | -- |
| Kura Oncology Inc | 3.171 |
Price to Book Value Related Metrics
| Price | 2.085 |
| Earnings Yield | -69.54% |
| Market Cap | 107.26M |